# Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

> **NCT02309385** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aciont Inc** · enrollment: 44 (actual)

## Conditions studied

- Non-Infectious Anterior Uveitis

## Interventions

- **DRUG:** 8% Dexamethasone Sodium Phosphate - Visulex
- **DRUG:** 15% Dexamethasone Sodium Phosphate - Visulex
- **DRUG:** Prednisolone Acetate (1%) Eye Drops

## Key facts

- **NCT ID:** NCT02309385
- **Lead sponsor:** Aciont Inc
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-03-03
- **Final completion:** 2017-03-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02309385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02309385, "Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02309385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*